Alert: New Earnings Report (4/24/24)-Biomarin Pharmaceutical Inc (NASDAQ: BMRN).
For its first fiscal quarter (ending March 31), Biomarin Pharmaceutical Inc (NASDAQ: BMRN) has reported E.P.S. of $0.47 compared to $0.27 a year ago. E.P.S. were $1.09 for the latest four quarters through March 31 […]